MED Quote, Financials, Valuation and Earnings

Driven Brands Holdings, Inc. has a net margin of -24.13% compared to Medifast, Inc.'s net margin of 11.33%. Medifast, Inc.'s return on equity of -8.89% beat Driven Brands Holdings, Inc.'s return on equity of -28.88%.

Medifast, Inc. has a consensus price target of $12.00, signalling upside risk potential of 12.05%. On the other hand Driven Brands Holdings, Inc. has an analysts' consensus of $19.35 which suggests that it could grow by 73.08%. Given that Driven Brands Holdings, Inc. has higher upside potential than Medifast, Inc., analysts believe Driven Brands Holdings, Inc. is more attractive than Medifast, Inc..

Medifast, Inc. has a beta of 0.522, which suggesting that the stock is 47.836% less volatile than S&P 500. In comparison Driven Brands Holdings, Inc. has a beta of 1.087, suggesting its more volatile than the S&P 500 by 8.707%.

Medifast, Inc. has a quarterly dividend of $1.65 per share corresponding to a yield of 0%. Driven Brands Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medifast, Inc. pays -- of its earnings as a dividend. Driven Brands Holdings, Inc. pays out -- of its earnings as a dividend.

Medifast, Inc. quarterly revenues are $75.1M, which are smaller than Driven Brands Holdings, Inc. quarterly revenues of $535.7M. Medifast, Inc.'s net income of -$18.1M is lower than Driven Brands Holdings, Inc.'s net income of $60.7M. Notably, Medifast, Inc.'s price-to-earnings ratio is 516.75x while Driven Brands Holdings, Inc.'s PE ratio is 391.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medifast, Inc. is 0.31x versus 0.83x for Driven Brands Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Eventiko, Inc. has a net margin of -24.13% compared to Medifast, Inc.'s net margin of --. Medifast, Inc.'s return on equity of -8.89% beat Eventiko, Inc.'s return on equity of --.

Medifast, Inc. has a consensus price target of $12.00, signalling upside risk potential of 12.05%. On the other hand Eventiko, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Medifast, Inc. has higher upside potential than Eventiko, Inc., analysts believe Medifast, Inc. is more attractive than Eventiko, Inc..

Medifast, Inc. has a beta of 0.522, which suggesting that the stock is 47.836% less volatile than S&P 500. In comparison Eventiko, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Medifast, Inc. has a quarterly dividend of $1.65 per share corresponding to a yield of 0%. Eventiko, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medifast, Inc. pays -- of its earnings as a dividend. Eventiko, Inc. pays out -- of its earnings as a dividend.

Medifast, Inc. quarterly revenues are $75.1M, which are larger than Eventiko, Inc. quarterly revenues of --. Medifast, Inc.'s net income of -$18.1M is lower than Eventiko, Inc.'s net income of -$4.3K. Notably, Medifast, Inc.'s price-to-earnings ratio is 516.75x while Eventiko, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medifast, Inc. is 0.31x versus -- for Eventiko, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Interactive Strength, Inc. has a net margin of -24.13% compared to Medifast, Inc.'s net margin of -108.64%. Medifast, Inc.'s return on equity of -8.89% beat Interactive Strength, Inc.'s return on equity of -163.73%.

Medifast, Inc. has a consensus price target of $12.00, signalling upside risk potential of 12.05%. On the other hand Interactive Strength, Inc. has an analysts' consensus of $22.50 which suggests that it could grow by 1200.58%. Given that Interactive Strength, Inc. has higher upside potential than Medifast, Inc., analysts believe Interactive Strength, Inc. is more attractive than Medifast, Inc..

Medifast, Inc. has a beta of 0.522, which suggesting that the stock is 47.836% less volatile than S&P 500. In comparison Interactive Strength, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Medifast, Inc. has a quarterly dividend of $1.65 per share corresponding to a yield of 0%. Interactive Strength, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medifast, Inc. pays -- of its earnings as a dividend. Interactive Strength, Inc. pays out -- of its earnings as a dividend.

Medifast, Inc. quarterly revenues are $75.1M, which are larger than Interactive Strength, Inc. quarterly revenues of $4.8M. Medifast, Inc.'s net income of -$18.1M is lower than Interactive Strength, Inc.'s net income of -$5.2M. Notably, Medifast, Inc.'s price-to-earnings ratio is 516.75x while Interactive Strength, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medifast, Inc. is 0.31x versus 0.01x for Interactive Strength, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Valvoline, Inc. has a net margin of -24.13% compared to Medifast, Inc.'s net margin of -6.97%. Medifast, Inc.'s return on equity of -8.89% beat Valvoline, Inc.'s return on equity of 30.84%.

Medifast, Inc. has a consensus price target of $12.00, signalling upside risk potential of 12.05%. On the other hand Valvoline, Inc. has an analysts' consensus of $41.60 which suggests that it could grow by 12.62%. Given that Valvoline, Inc. has higher upside potential than Medifast, Inc., analysts believe Valvoline, Inc. is more attractive than Medifast, Inc..

Medifast, Inc. has a beta of 0.522, which suggesting that the stock is 47.836% less volatile than S&P 500. In comparison Valvoline, Inc. has a beta of 1.160, suggesting its more volatile than the S&P 500 by 15.961%.

Medifast, Inc. has a quarterly dividend of $1.65 per share corresponding to a yield of 0%. Valvoline, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medifast, Inc. pays -- of its earnings as a dividend. Valvoline, Inc. pays out -- of its earnings as a dividend.

Medifast, Inc. quarterly revenues are $75.1M, which are smaller than Valvoline, Inc. quarterly revenues of $461.8M. Medifast, Inc.'s net income of -$18.1M is higher than Valvoline, Inc.'s net income of -$32.2M. Notably, Medifast, Inc.'s price-to-earnings ratio is 516.75x while Valvoline, Inc.'s PE ratio is 54.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medifast, Inc. is 0.31x versus 2.69x for Valvoline, Inc.. Usually stocks with elevated PS ratios are considered overvalued.